🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multicenter Phase 1b study evaluating the safety, tolerability, a...
Status
Completed
Location
City of Hope
Start Date
2021-07-29
Trial ID
NCT05075603
Treatments Being Tested
This randomized phase II trial studies how well glycosylated recombinant hu...
Status
Completed
Location
UC San Diego Moores Cancer Center
Start Date
2013-09-10
Trial ID
NCT01881867
Treatments Being Tested
The main purposes of this study is to determine the following in participan...
Status
Terminated
Location
Nih/Niaid
Start Date
2020-11-27
Trial ID
NCT04501796
Treatments Being Tested
This study is a phase 1b clinical trial to investigate the safety and preli...
Status
Terminated
Location
Borame Medical Center
Start Date
2021-03-24
Trial ID
NCT04730427
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of GX-I7 i...
Status
Unknown
Location
Seoul St.Mary's Hospital of the Catholic University of Korea
Start Date
2022-01-26
Trial ID
NCT05191784
Treatments Being Tested
This study will evaluate the safety of a new experimental drug, IL-7, in pe...
Status
Completed
Location
University of Miami School of Medicine
Start Date
2007-05
Trial ID
NCT00477321
Treatments Being Tested
Background: * Pediatric solid tumors (Ewing's sarcoma, rhabdomyosarcoma, a...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2007-06-02
Trial ID
NCT00923351
This phase II trial studies how well atezolizumab when given with glycosyla...
Status
Completed
Location
Kaiser Permanente-Riverside
Start Date
2019-06-05
Trial ID
NCT03513952
This phase I trial evaluates the side effects of NT-I7 in treating patients...
Status
Terminated
Location
University of California San Francisco
Start Date
2021-03-12
Trial ID
NCT04588038
Treatments Being Tested
This phase I trial studies the best dose and effects of NT-I7 in treating K...
Status
Terminated
Location
Zuckerberg San Francisco General Hospital
Start Date
2022-05-23
Trial ID
NCT04893018
Treatments Being Tested